CareDx Announces Revised Agreement to Purchase 78% Outstanding Shares of Allenex AB

CareDx, Inc.

today announced a revision to the terms of its public offer to the shareholders of Allenex AB

S+). Under the agreements entered into on December 16, 2015, the three principal Allenex shareholders, collectively owning 78% of the outstanding shares (the "Majority Shareholders"), agreed with CareDx to tender their shares for a combination of cash and CareDx common stock that valued Allenex at approximately $35 million. Under the original terms, $6 million of the cash consideration to the Majority Shareholders would be made contingent on Allenex achieving certain commercial and financial milestones in 2016. Under the revised terms, CareDx and the Majority Shareholders have agreed to defer the payment of these milestones until March 31, 2017, if earned.  In addition, the Majority Shareholders will be issued a total of 150,000 additional shares of CareDx common stock.  This deferred milestone payment only applies to the Majority Shareholders. CareDx is also revising the cash and common stock alternative offered to the remaining 22% of